This case describes the procedure for getting Adisseo of France in 2006 by Bluestar Group, the biggest subsidiary of ChemChina (a Fortune 500 company). Adisseo was primarily engaged in production of methionine, a feed additive, while China had relied on its import for quite a long time and had no methionine creation. Bluestar began to convey with Adisseo when Adisseo wasn't interested to acquire the technology of the latter in 2000. The global burst of bird flu in 2004 provided Bluestar a historic chance to purchase Adisseo. Later, together with the help of intermediate agencies in the fields of strategy, bookkeeping, legal affairs, etc.
Bluestar reached an arrangement with CVC, Adisseo's parent company, on Oct. 20, 2005, to buy the whole Adisseo with EUR400m. The transaction was completed on Jan. 17, 2006. RenJianxin, President of Bluestar, was quite excited by a French company's biggest M&A by a Chinese company in history. Next, he needed to think about just make the integration of adisseo develop well and the best way to complete it.
PUBLICATION DATE: November 30, 2014 PRODUCT #: TU0070-PDF-ENG
This is just an excerpt. This case is about GLOBAL BUSINESS
Related Case Solutions & Analyses:
Digital Imaging in 1995: Opportunities in the Descent to the Desktop
MSA: The Software Company–Planning the AMAPs Product Line
Competition and Product Variety
Ellen Moore (A): Living and Working in Bahrain
Tata Group
The Man in the Mirror (B)
Janet Yellen and the Bernanke Fed
Striking at the Queen
Banco Ciudad (B): Transformation at Work
China´s Challenge to Feed Its People
